Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

English version České info

Background:
Depressive disorders were a leading cause of burden in the Global Burden of Disease (GBD) 1990 and 2000 studies. Here, we analyze the burden of depressive disorders in GBD 2010 and present severity proportions, burden by country, region, age, sex, and year, as well as burden of depressive disorders as a risk factor for suicide and ischemic heart disease.

Methods and Findings:
Burden was calculated for major depressive disorder (MDD) and dysthymia. A systematic review of epidemiological data was conducted. The data were pooled using a Bayesian meta-regression. Disability weights from population survey data quantified the severity of health loss from depressive disorders. These weights were used to calculate years lived with disability (YLDs) and disability adjusted life years (DALYs). Separate DALYs were estimated for suicide and ischemic heart disease attributable to depressive disorders.

Depressive disorders were the second leading cause of YLDs in 2010. MDD accounted for 8.2% (5.9%–10.8%) of global YLDs and dysthymia for 1.4% (0.9%–2.0%). Depressive disorders were a leading cause of DALYs even though no mortality was attributed to them as the underlying cause. MDD accounted for 2.5% (1.9%–3.2%) of global DALYs and dysthymia for 0.5% (0.3%–0.6%). There was more regional variation in burden for MDD than for dysthymia; with higher estimates in females, and adults of working age. Whilst burden increased by 37.5% between 1990 and 2010, this was due to population growth and ageing. MDD explained 16 million suicide DALYs and almost 4 million ischemic heart disease DALYs. This attributable burden would increase the overall burden of depressive disorders from 3.0% (2.2%–3.8%) to 3.8% (3.0%–4.7%) of global DALYs.

Conclusions:
GBD 2010 identified depressive disorders as a leading cause of burden. MDD was also a contributor of burden allocated to suicide and ischemic heart disease. These findings emphasize the importance of including depressive disorders as a public-health priority and implementing cost-effective interventions to reduce its burden.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001547
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001547

Souhrn

Zdroje

1. FerrariAJ, SomervilleAJ, BaxterAJ, NormanR, PattenSB, et al. (2013) Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psycho Med 43: 471–481.

2. FerrariAJ, CharlsonFJ, NormanR, FlaxmanAD, PattenSB, et al. (2013) The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS ONE 8: e69637 doi:10.1371/journal.pone.0069637

3. CharlsonFJ, FerrariAJ, SomervilleAJ, NormanR, PattenSB, et al. (2013) The epidemiological modelling of dysthymia: application for the Global Burden of Disease 2010 Study. J Affect Disord 151: 111–120.

4. Murray CJL, Lopez AD, editors (1996) The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (Massachusetts): Harvard School of Public Health on behalf of the World Health Organization & the World Bank.

5. World Health Organization (2008) The Global Burden of Disease: 2004 update. Switzerland. Available: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/

6. Mathers CD, Stein C, Ma Fat D, Rao C, Inoue M, et al.. (2002) Global Burden of Disease 2000: version 2 methods and results. Geneva: World Health Organization. Available: http://www.who.int/healthinfo/paper50.pdf

7. World Bank (1993) World Development Report 1993. Investing in health: world development indicators. New York: World Bank. Available: http://files.dcp2.org/pdf/World Development Report 1993.pdf

8. UstunTB, Ayuso-MateosJL, ChatterjiS, MathersC, MurrayCJ (2004) Global burden of depressive disorders in the year 2000. Br J Psychiatry 184: 386–392.

9. PrinceM, PatelV, SaxenaS, MajM, MaselkoJ, et al. (2007) No health without mental health. Lancet 370: 859–877.

10. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Washington (D.C.): American Psychiatric Association.

11. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.

12. Ayuso-Mateos JL (2000) Global burden of bipolar disorder in the year 2000: version 1. Geneva: World Health Organization. Available: http://www.who.int/healthinfo/statistics/bod_bipolar.pdf

13. MurrayCJL, EzzatiM, FlaxmanA, LimS, LozanoR, et al. (2012) GBD 2010: design, definitions, and metrics. Lancet 380: 2063–2066.

14. MurrayCJL, VosT, LozanoR, NaghaviM, FlaxmanAD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197–2223.

15. LimSS, VosT, FlaxmanAD, DanaeiG, ShibuyaK, et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224–2260.

16. LozanoR, NaghaviM, ForemanK, LimS, ShibuyaK, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095–2128.

17. SalomonJA, VosT, HoganDR, GagnonM, NaghaviM, et al. (2012) Common values in assessing health outcomes from disease and injury:disability weights measurement study for the Global Burden of Disease 2010. Lancet 380: 2129–2143.

18. VosT, FlaxmanAD, NaghaviM, LozanoR, MichaudC, et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2163–2196.

19. WhitefordHA, DegenhardtL, RehmJ, BaxterAJ, FerrariAJ, et al. (2013) The Global Burden of Mental and Substance Use Disorders, 2010. Lancet In press.

20. MoherD, LiberatiA, TetzlaffJ, AltmanDG, ThePG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 6: e1000097 doi:10.1371/journal.pmed.1000097

21. KruijshaarME, BarendregtJ, VosT, de GraafR, SpijkerJ, et al. (2005) Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias. Eur J Epidemiol 20: 103–111.

22. MoffittTE, CaspiA, TaylorAJ, KokauaJ, MilneBJ, et al. (2010) How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psycho Med 40: 899–909.

23. SimonGE, VonKorffM (1995) Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research. Epidemiol Rev 17: 221–227.

24. SusserE, ShroutPE (2010) Two plus two equals three? Do we need to rethink lifetime prevalence? A commentary on ‘How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment’ by Moffitt et al. (2009). Psycho Med 40: 895–897.

25. BaxterAJ, PageA, WhitefordHA (2011) Factors influencing risk of premature mortality in community cases of depression: a meta-analytic review. Epidemiology Research International 2011: 1–12.

26. VosT, HabyMM, BarendregtJJ, KruijshaarM, CorryJ, et al. (2004) The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatr 61: 1097–1103.

27. BarendregtJJ, Van OortmarssenGJ, VosT, MurrayCJ (2003) A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr 1: 4.

28. Agency for Healthcare Research and Quality (2012) United States Medical Expenditure Panel Survey 2000–2009. Rockville (Maryland): Agency for Healthcare Research and Quality. Available: http://meps.ahrq.gov/mepsweb/.

29. U.S. National Institutes of Health National Institute on Alcohol Abuse and Alcoholism (2013) National Epidemiologic Survey on Alcohol and Related Conditions Wave 1 and Wave 2. Bethesda (Maryland): National Institutes of Health. Available: http://www.niaaa.nih.gov/

30. Australian Bureau of Statistics (2008) National Survey of Mental Health and Wellbeing of Adults 1997. Canberra: Australian Bureau of Statistics. Available: http://www.abs.gov.au/AUSSTATS/abs.nsf/allprimarymainfeatures/D5A0AC778746378FCA2574EA00122887?opendocumen.

31. Ware JE, Kosinski M, Keller SD, QualityMetric Incorporated, New England Medical Center Hospital. Health Assessment Lab (2002) SF-12: how to score the SF-12 physical and mental health summary scales. Lincoln (Rhode Island); Boston: QualityMetric Inc, Health Assessment Lab.

32. BaxterAJ, CharlsonFJ, SomervilleAJ, WhitefordHA (2011) Mental disorders as risk factors: assessing the evidence for the global burden of disease study. BMC Medicine 9: 1–7.

33. CharlsonFJ, StapelbergNJC, BaxterA, WhitefordHA (2011) Should Global Burden of Disease estimates include depression as a risk factor for coronary heart disease? BMC Medicine 9: 1–6.

34. LiZ, PageA, MartinG, TaylorR (2011) Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review. Soc Sci Med 72: 608–616.

35. EatonWW, KalaydjianA, ScharfsteinD, MezukB, DingY (2007) Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981–2004. Acta Psychiatrica Scandinavica 116: 182–188.

36. FuTS, LeeCS, GunnellD, LeeWC, ChengAT (2012) Changing trends in the prevalence of common mental disorders in Taiwan: a 20-year repeated cross-sectional survey. Lancet 381: 235–241.

37. CharlsonFJ, SteelZ, DegenhardtL, CheyT, SiloveD, et al. (2012) Predicting the impact of the 2011 conflict in Libya on population mental health: PTSD and depression prevalence and mental health service requirements. PLoS ONE 7: e40593 doi:10.1371/journal.pone.0040593

38. GBD 2010 Country Collaboration (2013) GBD 2010 country results: a global public good. Lancet 381: 965–970.

39. JessopEG (2013) Health in the UK: could do even better? Lancet 381: 970–972.

40. MurrayCJL, RichardsMA, NewtonJN, FentonLA (2013) UK health performance: fi ndings of the Global Burden of Disease Study 2010. Lancet 381: 997–1020.

41. McKnightPE, KashdanTB (2009) The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev 29: 243–259.

42. Kessler RC, Ustun TB, editors (2008) The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press.

43. SheehanKH, SheehanDV (2008) Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol 23: 70–83.

44. SheehanDV, Harnett-SheehanK, RajBA (1996) The measurement of disability. Int Clin Psychopharm 11 (Suppl 3) 89–95.

45. KesslerRC, BerglundP, DemlerO, JinR, KoretzD, et al. (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095–3105.